MedTrace Logo

[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse

NCT04719208 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-02-01

No results posted yet for this study

Summary

The purpose of this study is to test the effectiveness of prophylactic mouth rinses in reducing the amount of viruses, specifically SARS-CoV-2 in the oral cavity. This research will guide dental and medical providers on best practices to be performed prior to dental and medical procedures involving the oral cavity.

Conditions

  • Covid19

Interventions

OTHER

Water (E) Mouth rinse with the solution provided

Subject will be asked to perform a simple mouth rinse for 2 minutes with one of the 5 mouth washes to be tested.

OTHER

Chlorhexidine gluconate (A) Mouth rinse with the solution provided

Subject will be asked to perform a simple mouth rinse for 2 minutes with one of the 5 mouth washes to be tested.

OTHER

Hydrogen peroxide (B) Mouth rinse with the solution provided

Subject will be asked to perform a simple mouth rinse for 2 minutes with one of the 5 mouth washes to be tested.

OTHER

Betadine (C) Mouth rinse with the solution provided

Subject will be asked to perform a simple mouth rinse for 2 minutes with one of the 5 mouth washes to be tested.

OTHER

Alcohol mouthwash (Listerine) (D) Mouth rinse with the solution provided

Subject will be asked to perform a simple mouth rinse for 2 minutes with one of the 5 mouth washes to be tested.

Sponsors & Collaborators

  • Augusta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2023-07-01
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719208 on ClinicalTrials.gov